Can a pharmacokinetic approach to immunosuppression eliminate ethnic disparities in renal allograft outcome?

Clinical Transplantation

Volumn 16, Issue SUPPL. 7, 2002, Pages 45-48

  Emovon, Osemwegie E ^a,b   Holt, Cindy Op't ^a   Browne, Barry J ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

African Americans; Cyclosporin pharmacokinetics; Kidney transplantation; Renal allograft outcome

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; CYCLOSPORIN; DRUG DERIVATIVE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

AFRICAN AMERICAN; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; ETHNIC DIFFERENCE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME; ADULT; ETHNOLOGY; MIDDLE AGED;

ADULT; AREA UNDER CURVE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; TREATMENT OUTCOME;

EID: 0036369171     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.16.s7.6.x     Document Type: Article

References (17)

1. HARIHARAN S, JOHNSON CP, BRESNAHAN BA, TARANTO SE, MCINTOSH MJ, STABLEIN D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000: 342 (9): 605.
2. FIRST MR, SCHROEDER TJ, MONACO AP, SIMPSON MA, CURTIS JJ, ARMENTI VT. Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplant populations. Clin Transplant 1996: 10 (1 Part 1): 55.
3. SENEL MF, VAN BUREN CT, WELSH M et al. Impact of early cyclosporine average blood concentration on early kidney transplant failure. Transplant Int 1998: 11: 46.
4. MAHALATI K, BELITSKY P, SKETRIS I, WEST K, PANEK R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999: 68 (1): 55.
5. LINDHOLM A, KAHN BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993: 54 (2): 205.
6. BROWNE BJ, OP'T HOLT C, EMOVON OE. Diurinal cyclosporine dosing optimizes exposure and reduces the risk of acute rejection after kidney transplantation. Clin Transplant 2001: 15 (Suppl. 6): 51-54
7. AMANTE A, KAHAN BD. Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period. Clin Chem 1996: 42 (8): 1294.
8. RACUSEN LC, SOLEZ K, COLVIN RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55 (2): 713.
9. HARIHARAN S, ALEXANDER JW, SCHROEDER TJ, FIRST MR. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival. Clin Transplant 1996: 10 (6 Part 1): 538.
10. KNIGHT RJ, BURROWS L, BODIAN C. The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation. Transplantation 2001: 72 (1): 69.
11. MATAS AJ, GILLINGHAM KJ, PAYNE WD, NAJARIAN JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994: 57 (6): 857.
12. VALENTE JF, HARIHARAN S, PEDDI VR et al. Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era. Clin Transplant 1997: 11 (3): 231.
13. OJQ AO, PORT FK, HELD PJ et al. Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection. Kidney Int 1995: 48 (5): 1592.
14. HARIHARAN S, SCHROEDER TJ, FIRST MR. Effect of race on renal transplant outcome. Clin Transplant 1993: 7 (3): 235.
15. PEREIRA BJG, WRIGHT TL, SCHMID CH, LEVEY AS. The impact of pretransplant hepatitis C infection on the outcome of renal transplantation. Transplantation 1995: 60: 799.
16. OELLERICH M, AMSTRONG VW, KAHAN B et al. Lake Louise concensus conference on cyclosporine monitoring in organ transplantation: report of the concensus panel. Ther Drug Monit 1995: 17: 642.
17. NANKIVELL BJ, HIBBINS M, CHAPMAN JR. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy. Transplantation 1994: 58: 989.